| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |